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Abstract: The 15q duplication syndrome (dup15q) is due to the presence of at least one additional
derived copy of the Prader–Willi syndrome/Angelman syndrome (PWS/AS) critical region that is
approximately 5 Mb long within chromosome 15q11.2-q13.1. This report describes distinct roles of
the origin of interstitial (int) dup15q underlining the critical importance of maternally active im-
printed genes in the contribution to complete penetrance but different phenotypes of neuropsychotic
disorders such as schizophrenia (SCZ) and autism spectrum disorder (ASD) in a Korean family. The
proband’s mother as a consultant visited our hospital for her offspring’s genetic counseling and
segregation analysis. She had two daughters diagnosed as SCZ or ASD and one son diagnosed as
ASD. To resolve the potential genetic cause of SCZ and ASD in the proband and her sibling, whole
genomic screening of chromosomal rearrangements by array-comparative genomic hybridization
(CGH) was performed using SurePrint G3 Human CGH + SNP Microarray 4 × 180 K. Results of the
array-CGH analysis revealed an interstitial duplication at 15q11.2-q13.1 (duplication size of 5.4 Mb)
in the mother and her three offspring with SCZ or ASD. Our case, together with previous findings
of high occurrence of psychotic disorder, suggest that maternally expressed gene product in the
critical region of PWS/AS might mediate the risk of neurodevelopmental disorder (ASD) as well
as psychotic disorder (SCZ). Multiple cytogenetic and molecular methods are recommended for
investigating children with 15q11.2-q13.1 duplication and neuropsychotic disorders.
Keywords: maternal origin; interstitial duplication; 15q11.2-q13.1; schizophrenia; autism spectrum
disorder; different phenotypes
1. Introduction
The 15q duplication syndrome (dup15q) is due to the presence of at least one addi-
tional derived copy of the Prader–Willi syndrome/Angelman syndrome (PWS/AS) critical
region that is about 5 Mb long within chromosome 15q11.2-q13.1 [1]. The occurrence of
dup15q in the overall population is unclear. It might be as high as 1:5000 [2]. Particularly,
in patients referred for medical genetic testing because of neurodevelopmental concerns
(autism spectrum disorder, ASD; intellectual disability, ID; developmental delay, DD)
or multiple congenital anomalies, the incidence of dup15q is about 1:508 [3]. The addi-
tional copy (or copies) most frequently arises by one of two principles: (1) an interstitial
15q11.2-q13.1 duplication (int dup15q) (typically one additional copy of 15q11.2-q13.1
within chromosome 15) that leads to trisomy for 15q11.2-q13.1; and (2) an isodicentric
15q11.2-q13.1 supernumerary chromosome (namely idic(15)) comprising typically two
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additional copies of 15q11.2-q13.1 that causes tetrasomy for 15q11.2-q13.1. Dup15q should
be suspected in a patient with moderate to severe hypotonia in infancy and motor delays,
ASD, DD/ID manifesting as speech and language delays, and infantile spasms. Dup15q
resulting from maternal int dup15q has been found to be de novo in 85% and inherited
from the mother in 15%. It is penetrant fully for ASD [4]. Rarely, dup15q may also be
associated with psychotic disorder (such as schizophrenia, SCZ) and sudden unexplained
death. Those with maternal idic(15) are affected more severely than those with an int
dup15q [5].
Here, we describe a maternal origin of interstitial duplication at 15q11.2-q13.1 in the
contribution to variable expressivity of neuropsychotic disorders such as SCZ and ASD in
a Korean family
2. Case Presentation
The proband’s mother (I-2 in Figure 1A), a 45-year-old female, visited the Department
of Pediatric Neurology, Daejeon St. Mary’s Hospital (Daejeon, Korea) for her offspring’s
genetic counseling and segregation analysis. Her development was completely normal
through birth to adolescent without learning difficulties. She has four sisters and six
nephews. None of them had a family history of neurodevelopmental delay, mental retarda-
tion, or psychotic disorders. The proband (II-1 in Figure 1A) was a 15-year-old female with
neuropsychotic problems. She was referred for genetic diagnosis. She was the first child of
non-consanguineous parents. The pregnancy was uneventful. Except for a history of ASD
in her siblings, there was no history of neurological disorders including epilepsy, DD/ID,
or psychotic disorders. She has neither facial dysmorphism nor anomaly. In childhood,
her growth and developmental milestones were normal. After entering middle school,
she began to show cognitive changes, immaturity, and worsen social communication that
affected her ability to function in the school. She gradually developed problem behaviors
with attention deficit and hyperactivity. She suffered from unpredictable agitation and
bizarre posture. She seemed seeing or hearing somethings that did not exist. Effective
communication was impaired and answers to questions were completely unrelated. Assess-
ment for 15 years of age confirmed a diagnosis of SCZ. Since the diagnosis, she has been
taking risperidone, clozapine, and fluoxetine. At age of 16, her intellectual quotient (IQ)
was estimated to be 65, indicating mild ID. She is currently educated in a specialized school
due to some problems in learning basic academic skills. The proband’s brother (II-2 in
Figure 1A), a 13-year-old male, was the second child of non-consanguineous parents. The
pregnancy was uneventful. When he first attended kindergarten, he was not interested in
other children. He made unusual finger movements near his face and repeated some words
without intent to communicate. He also had trouble starting a conversation. Assessment at
6 years of age confirmed a diagnosis of ASD. Since then, he has been taking risperidone.
He attained an IQ of 60 on the Wechsler Intelligence Scale for Children Revised indicating
mild intellectual disability. The proband’s sister (II-3 in Figure 1A), an 11-year-old female,
was the third child of non-consanguineous parents. The pregnancy was uneventful. Early
development was characterized by a delay in achieving fine motor, social-cognitive, and
language milestones. At 5 years of age, she became aggressive and would hit her parents
and throw objects. She displayed repetitive behaviors, including touching objects, opening
and closing doors, and asking the same question many times. An assessment at 7 years of
age confirmed a diagnosis of ASD. Since then, she has been taking methylphenidate and
risperidone. Her IQ was estimated at 58.
Careful etiologic investigations of laboratory and radiology studies were performed.
All results were within normal ranges for all of them (the proband and her siblings).
Chromosomal analysis also revealed normal female karyotype. Fragile X testing was
negative. Metabolic laboratory testing was within normal limits.
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Figure 1. Pedigree analysis and array–comparative genomic hybridization in the proband. (A) Family pedigree depicting
maternal origin of interstitial duplications at 15q11.2-q13.1 in a Korean family with schizophrenia and autism spectrum
disorder. The grey symbol indicates affected individual. SCZ, schizophrenia; ASD: autism spectrum disorders. (B) Array–
comparative genomic hybridization identifies interstitial duplications at 15q11.2-q13.1 between breakpoint 2 and 3 in the
proband. The arr 15q11.2q13.1 (23,290,787_28,704,050) ×3 involving genes: ATP10A, GABRA5, GABRB3, GABRG3, HERC2,
MAGEL2, MKRN3, NDN, NPAP1, OCA2, PWRN1, PWRN2, SNHG14, SNORD115-1, SNORD116-1, SNRPN, and UBE3A.
3. Results
Genomic DNA samples were obtained from leukocytes of peripheral blood using
a QIAamp DNA Mini Kit (Qiagen GmbH, Hilden, Germany) according to the standard
DNA isolation process. Their quantity and quality were estimated with a NanoDrop
ND-1000 (ThermoFisher Scientific, Waltham, MA, USA) and a Qubit 1.0 (ThermoFisher
Scientific), respectively. To resolve the potential genetic cause of SCZ and ASD in the
proband and her sibling, whole genomic screening of chromosomal rearrangements by
array-comparative genomic hybridization (CGH) was performed using SurePrint G3 Hu-
man CGH + SNP Microarray 4 × 180 K (Agilent Technologies, Santa Clara, CA, USA)
according to the manufacturers’ instructions. All samples were matched with Human
Genomic DNA reference (Promega, Madison, WI, USA). Data were obtained using Agilent
Feature Extraction software 12.0.2.2 and Agilent CytoGenomics 4.0 and visually assessed
using Agilent Genomic Workbench Software 7.0.4.0 and Agilent CytoGenomics 4.0. Copy
number variations (CNVs) were identified using the ADM-2 algorithm with the following
filters: minimal absolute average log ratio of 0.25 as a cut-off, >5 Mb of copy number neutral
loss of heterozygosity regions, and minimal size of 200 Kb in region. Genomic positions
were mapped using the human genomic reference sequence GRCh37/hg19. As a result,
array-CGH analysis revealed an interstitial duplication at 15q11.2-q13.1 (duplication size
of 5.4 Mb), in the proband and her siblings. Because the diagnosis of dup15q is established
by identification of at least one extra maternally derived copy of the PWS/AS critical
region, genetic counseling and segregation analysis were recommended for the proband’s
parents. Same interstitial 15q duplication was detected only in her mother (Figure 1B).
Other rare CNVs classified as likely pathogenic were not identified in the proband and her
family members.
Since clinical manifestation of the proband differs from her siblings, additional molec-
ular analysis at the nucleotide level was performed in the proband only. Exomic DNA of
the proband was enriched using the Agilent’s SureSelect XT Human All Exon v5 (Agilent
Technologies) and paired-end sequenced using an Illumina HiSeq2500 (Illumina, San Diego,
CA, USA) for detection of the variant considering possible familial disease. Base calling,
alignment, variant calling, annotation, and quality control reporting were performed us-
ing a GATK Best Practices workflow for germline short variant discovery and manually
reviewed by medical laboratory geneticists. However, whole exome sequencing (WES)
identified no likely pathogenic variants that may correlate with clinical phenotypes such as
ID or SCZ of the proband.
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4. Discussion
The dup15q may be one of the most common single genetic causes of ASD besides
Fragile X syndrome [6]. Although penetrance appears to be complete in maternal int
dup15q, some patients may show mild clinical manifestations and appear to be unaffected,
reflecting different phenotypes rather than true non-penetrance. However, penetrance of
maternal idic(15) always occurs with variable expressivity [7]. PWS/AS critical region is
always included in the idic(15) or the interstitial duplications which lead to dup15q. When
the PWS/AS critical region is imprinted, maternally derived increases in copy number
lead to dup15q, whereas paternally derived increases are usually related to more diverse
and variable neurodevelopmental symptoms [8]. The degree of clinical symptom varies
even among patients with the same genetic mechanism due to a gene dosage effect, by
deletion or duplication. Some phenotypic characteristics such as ASD are observed more
consistently in patients with a maternal large int dup15q that is more than 5 Mb long or
idic(15) which extends beyond the PWS/AS critical region [8,9].
On the other hand, Phenotypes resulting from paternal and maternal duplications
can differ, because this duplicated region is imprinted. In our siblings, the maternal int
dup15q resulted in different phenotypes of neuropsychotic disorders such as SCZ and
ASD in a Korean family. Interestingly, the mother is normal. However, her three offspring
showed SCZ or ASD, although all of them carried int dup15q. The relative risk to the
proband’s sibling depended on the genetic status of the proband’s mother. If the mother
carrying int dup15q inherited it from her father, she might appear to be unaffected or
show characteristics related to paternal duplications. These characteristics might share
some similarities, although they are distinct from those of the proband. However, it is not
possible to reliably predict the degree of phenotypic severity in the patient with dup15q [7].
Unfortunately, the origin of the mother’s int dup15q in our case was not determined
because array-CGH was not available for her parents.
Typical clinical manifestations of dup15q usually include ASD, language impairments,
DD/ID, and seizures [10]. Problematic behaviors including shouting, tantrums, aggres-
siveness, repetitive movements, and stereotypies are often found. Particularly autistic
characteristics might be present in up to 50% of affected patients [8]. Characteristics of
ASD, particularly difficulties with social interaction, might be frequent between early and
late childhood [11]. Conversely, psychotic disorder associated with a mood disorder with a
high occurrence of ASD in dup15q might be misdiagnosed as SCZ. Psychotic disorder is not
a commonly ascertained comorbidity in dup15q [12]. However, it is a common comorbidity
in PWS resulting from uniparental disomy that involves the maternal origin of dup15q
similarly [13]. There are somewhat overlapping similarities in clinical features among
15q11-q13 duplication, PWS, and AS (Table 1) [14–21]. However, SCZ is not a common
clinical manifestation associated with the 15q11-q13 region. Pediatric patients with early
onset of SCZ should be considered for duplication of this region. These patients tend to
have higher verbal and cognitive abilities than those with dup15q. Our case, together with
previous findings of high occurrence of psychotic disorder [22], suggest that maternally
expressed gene products in the critical region of PWS/AS might mediate the risk of neu-
rodevelopmental disorder (such as ASD) and psychotic disorder (such as SCZ). Because
there are some overlaps in phenotypic characteristics of maternal and paternal duplica-
tions, parent of origin testing should be estimated to determine whether the proband has a
maternal dup15q syndrome or a paternal interstitial duplication [8].
On the other hand, WES is a comprehensive approach for identifying novel candidate
genes and for suggesting de novo mutations that might contribute substantially to the
genetic risk for ASD [23] and SCZ [24]. Genomic instability of proximal 15q including five
regions of low copy repeats or segmental duplications designated by breakpoints (BPs) can
lead to higher susceptibility to genomic rearrangements [4]. Several genes crucial for brain
development and synaptogenesis, such as small nuclear ribonucleoprotein polypeptide
N (SNRPN), ubiquitin protein ligase E3A (UBE3A), and three gamma-aminobutyric acid
(GABA) type-A receptor genes (GABRA5, GABRB3, and GABRG3), have been reported [25].
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A part of the PWS/AS critical region between BP2 and BP3 involves several paternally
expressed genes (including MKRN3, MAGEL2, NDN, PWRN1, C15ORF2, and SNRPN) and
two maternally expressed genes (UBE3A and ATP10A) (Figure 2) [26].
Table 1. Comparison of clinical features of Prader–Willi, Angelman, and 15q11.2-q13.1 duplication syndromes and our
patients [14–21].




Hypotonia +++ + ++ Absent Absent Absent
Developmental delay ++ +++ ++ Absent Present Present
Intellectual disability + +++ ++ Present Present Present
Autism spectrum disorders + - + Absent Present Present
Behavioral problems ++ + ++ Present Present Present
Tremor and/or ataxia - +++ - Absent Absent Absent
Sleep disturbance ++ + - Absent Absent Absent
Seizures - ++ + Absent Absent Absent
Microcephaly - ++ - Absent Absent Absent
Strabismus - + - Absent Absent Absent
Failure to thrive +++ - - Absent Absent Absent
Feeding difficulty +++ - - Absent Absent Absent
Hypogonadism +++ - - Absent Absent Absent
Hyperphagia +++ - - Absent Absent Absent
Obesity +++ - - Absent Absent Absent
Short stature/reduced growth ++ - + Absent Absent Absent
Characteristic facial features ++ - + Absent Absent Absent
Small hand/feet ++ - - Absent Absent Absent
Happy demeanor - +++ - Absent Absent Absent
Hyperpigmentation - - + Absent Absent Absent
Hypopigmentation ++ - - Absent Absent Absent
PWS, Prader–Willi syndrome; AS, Angelman syndrome; Dup15q, 15q11.2-q13.1 duplication syndrome; +++, consistent (100%); ++, frequent
(80%); +, related (20–80%).
Figure 2. Map of 15q11.2-q13 region. (I) Interstitial duplication 15q11.2-q13 and (II) idic(15) or inv(15)dup. Gene distribution
between breakpoint (BP) 1 and BP5 on the proximal 15q region. 15q11.2-q13.1 region is located between BP2 and BP3. Genes
displayed by red and green boxes are imprinted and expressed from paternal and maternal alleles, respectively. Violet box
indicates silenced allele. Gray box marks genes expressed from both parental alleles. BP, break point; PWS, Prader–Willi
syndrome; IC, imprinting center.
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5. Conclusions
In conclusion, this report describes distinct roles of origin of int dup15q, underlining
the critical importance of maternally active imprinted genes in the contribution to complete
penetrance but different phenotypes of neuropsychotic disorders such as SCZ and ASD
in a Korean family. Multiple cytogenetic and molecular methods are recommended for
investigating children with 15q11.2-q13.1 duplication and neuropsychotic disorders.
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